Leadership Overview
Cepheid has 5 executives leading key functions including finance, technology, and medical affairs.
Driven by innovation, Cepheid is dedicated to advancing molecular diagnostics, automating complex genetic testing to empower institutions of all sizes with sophisticated solutions for identifying organisms and genetic-based diseases, thereby enhancing global health outcomes.
Driven by innovation, Cepheid is dedicated to advancing molecular diagnostics, automating complex genetic testing to empower institutions of all sizes with sophisticated solutions for identifying organisms and genetic-based diseases, thereby enhancing global health outcomes.
Leadership Roles at Cepheid
Charles Mwangi - Senior Vice President & Chief Financial Officer
Charles Mwangi, the Senior Vice President & Chief Financial Officer at Cepheid, directs all financial operations, ensuring fiscal health and strategic resource allocation. Mwangi oversees budgeting, forecasting, and financial reporting, aligning fiscal strategies with the company's mission to deliver advanced molecular diagnostic solutions. This leadership role involves managing capital, optimizing financial performance, and supporting the development and manufacturing of sophisticated genetic testing systems. By ensuring robust financial controls and driving efficient operations, Charles Mwangi directly contributes to Cepheid's capacity for innovation and market expansion in molecular diagnostics. Mwangi's oversight extends to investor relations and financial planning, securing the company's long-term stability and growth trajectory in the competitive healthcare technology sector.
Pawan Varshney - Interim Chief Financial Officer
Pawan Varshney, the Interim Chief Financial Officer at Cepheid, provides critical financial oversight during a transitional period, ensuring continuity in fiscal management. Varshney focuses on maintaining the integrity of financial reporting, managing cash flow, and supporting operational continuity for the development and manufacturing of molecular diagnostic systems. This role involves close collaboration with the executive team to uphold financial discipline and support strategic initiatives aimed at automating complex genetic testing. By guiding financial operations, Pawan Varshney ensures that Cepheid can continue its mission to provide sophisticated solutions for identifying organisms and genetic-based diseases. Varshney's interim leadership guarantees that financial functions remain robust, enabling the company to pursue its objectives without disruption.
James Green - Chief Technology Officer & Vice President, R&D
James Green, the Chief Technology Officer & Vice President, R&D at Cepheid, architects the technological vision and drives research and development initiatives. Green leads the innovation pipeline, focusing on advancing the company's molecular diagnostic platforms and expanding its portfolio of genetic testing solutions. This executive function involves overseeing the design, development, and implementation of sophisticated systems that automate complex manual procedures for organism and disease identification. By fostering a culture of scientific inquiry and technological excellence, James Green ensures Cepheid remains at the forefront of molecular diagnostics. Green's leadership in R&D directly fuels the company's ability to deliver cutting-edge solutions, enhancing diagnostic accuracy and accessibility for institutions worldwide.
Connie Price - Chief Medical Officer
Connie Price, the Chief Medical Officer at Cepheid, provides critical medical and scientific leadership, guiding the clinical strategy for molecular diagnostic solutions. Price oversees the clinical validation of new tests and systems, ensuring they meet rigorous medical standards and effectively address the identification of organisms and genetic-based diseases. This role involves translating complex scientific findings into practical applications that enhance patient care and public health outcomes. By championing evidence-based approaches, Connie Price ensures Cepheid's technologies offer reliable and sophisticated genetic testing capabilities. Price's medical expertise is vital in shaping the company's product development and market positioning, reinforcing its commitment to advancing diagnostic accuracy and accessibility globally.
David Persing - Executive VP, Chief Medical & Scientific Officer
David Persing, the Executive VP, Chief Medical & Scientific Officer at Cepheid, directs the company's overarching medical and scientific strategy, driving innovation in molecular diagnostics. Persing leads the integration of scientific discovery with clinical application, focusing on developing sophisticated genetic testing solutions for organisms and genetic-based diseases. This executive position involves overseeing research, clinical affairs, and regulatory science to ensure the efficacy and safety of Cepheid's automated diagnostic systems. By bridging scientific advancement and market needs, David Persing ensures the company delivers impactful technologies that automate complex manual procedures. Persing's dual leadership in medical and scientific domains is fundamental to Cepheid's mission of enhancing diagnostic capabilities worldwide.
Explore Leadership Teams in Manufacturing
Chamberlain Group is a company that owns and operates several brands that specializes in smart access solutions. The company is based in Oak Brook, Illinois.
Company Leadership
HG
Bruker Corporation is a global leader in scientific instrumentation, analytical technologies, and diagnostic solutions, serving customers across research, industry, and government. Operating through its Bruker Scientific Instruments and Bruker Energy & Supercon Technologies segments, the company provides a comprehensive portfolio that includes magnetic resonance systems, mass spectrometry and ion mobility instruments, infrared spectroscopy tools, radiological and nuclear detection technologies, X-ray and atomic force microscopy systems, fluorescence optical microscopy instruments, and advanced semiconductor metrology and defect-detection equipment. Bruker also manufactures handheld X-ray fluorescence devices, spark optical emission spectroscopy systems, and high-performance superconducting and non-superconducting materials used in renewable energy, healthcare, and scientific research. Its solutions support a wide range of industries and sectors, including pharmaceuticals, biotechnology, diagnostics, chemicals, food and beverage, semiconductors, forensics, academia, government, and environmental and clinical laboratories. Founded in 1960 and headquartered in Billerica, Massachusetts, Bruker delivers its products through direct sales teams, distributors, and independent representatives worldwide.
Company Leadership
JN
GH
WJ
Gilson is a third generation family-owned company. It develops liquid handling, purification, and extraction solutions with a focus on helping the life scientist. The company was founded in 1957 and is based in Middleton, Wisconsin.
Company Leadership RG
RO
EDMI PTY is one of the leading Smart Energy Solutions providers in the world. EDMI is focused on designing, developing and manufacturing innovative and technologically advanced energy meters and metering systems for the global utility industry. Their metering portfolio includes a comprehensive range of premium quality metering products, advanced infrastructure and energy management systems.
Company Leadership TM
EM
IB
Frequently Asked Questions Regarding Cepheid Top Executives and Leadership Team
Unlock more people and company data
